CD44 and breast carcinoma: The expression of the following CSC markers were evaluated: CD44+/CD24low/− and EpCAMneg/low/CD49fhigh/+; shown to be expressed by stem cells of normal and cancerous human breast tissue and breast cancer cell lines [30–33] and ALDH1 activity, a surrogate marker for stem cells [34].